Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Inverstigational Clinical Trial for the Safety and Efficacy Evaluation of Chondron(Autologous Cultured Chondrocyte)Compared With Mircrofracture Surgery in Subjects With Cartilage Defects of the Knee Joint

NCT02524509 is registered in ClinicalTrials.gov with Cellontech Co., Ltd. as lead sponsor.

NCT NCT02524509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Inverstigational Clinical Trial for the Safety and Efficacy Evaluation of Chondron(Autologous Cultured Chondrocyte)Compared With Mircrofracture Surgery in Subjects With Cartilage Defects of the Knee Joint
Lead sponsor
Cellontech Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
September 30, 2016
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage disorder of knee, defect of articular cartilage, degeneration; articular cartilage, knee